CPC Launches New Web Site Highlighting Medical, Research and Technical Panel, MedClose(TM) VCS Anim...( http://www.CPCMed ...),Health

http://www.CPCMedDevices.com provides latest information to medical and investment

communities

SARASOTA, Fla., Nov. 11 /PRNewswire-FirstCall/ -- CPC of America, Inc. (CPC) (OTC Bulletin Board: CPCF), today launched its new Web site, http://www.CPCMedDevices.com, to provide the medical and investment communities with a wealth of information on the company and its investigational product, MedClose(TM). CPC is a company focused on innovating medical devices that deliver improved safety and effectiveness and enhance the quality of patient care in endovascular procedures. It is pursuing worldwide commercial applications for MedClose(TM), an extravascular closure system (VCS) intended for use with a biological sealant to seal the femoral arterial puncture site following diagnostic or interventional catheterization procedures.

The Web site features CPC's panel of medical, research and technical advisors, which includes:

-- James R. Margolis, M.D., F.A.C.C., the pioneer of angioplasty in the Southeastern United States and the sixth person in the World to perform coronary angioplasty. He is American Board certified in Internal Medicine, Interventional Cardiology and Cardiovascular Disease.

-- Fred L. Ma, M.D., Ph. D., a board-certified neurosurgeon with more than 25 years of clinical experience and experience in the development and commercialization of more than 20 new drugs and medical devices.

-- Grace T. Bartoo, Ph. D., RAC, CBA, co-founder of Decus Biomedical with more than 25 years of seeing medical devices through clinical trials and regulatory approval.

-- Marc L. Bartoo, Ph. D., RAC, co-founder and technical services manager of Decus Biomedical, with expertise in regulatory affairs, design control, verification and validation.

-- Steve Jwanouskos, a regulatory and clinic
'/>"/>